Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.48 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.48 |
| ▸ | GALR3 | O60755 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30326816 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL31243393 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL30326809 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL30326720 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL6661477 | 0.94 | ALDH1A1 (0.64) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL315271 | 0.91 | ALDH1A1 (0.74) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL456552 | 0.91 | ALDH1A1 (0.54) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL20963870 | 0.91 | ALDH1A1 (0.54) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL2722997 | 0.91 | ALDH1A1 (0.82) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL13034068 | 0.91 | ALDH1A1 (0.82) | ALDH1A1TSHRCHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9242955-B2 | Synthesis of cyclic carbonates | UNIVERSITY OF YORK (GB) | 2016-01-26 | — | — | US | disclosed |
| US-8809432-B2 | Reusable print medium and method of manufacturing thereof | OCE TECHNOLOGIES B.V. (NL) | 2014-08-19 | — | — | US | disclosed |
| CN-101679343-B | Synthesis of cyclic carbonates in the presence of dimeric aluminium (salen) catalysts | UNIV NEWCASTLE | 2014-06-18 | — | — | CN | disclosed |
| US-20130137805-A1 | REUSABLE PRINT MEDIUM AND METHOD OF MANUFACTURING THEREOF | OCE TECHNOLOGIES B.V. (NL) | 2013-05-30 | — | — | US | disclosed |
| EP-2146977-B1 | SYNTHESIS OF CYCLIC CARBONATES IN THE PRESENCE OF DIMERIC ALUMINIUM (SALEN) CATALYSTS | UNIV NEWCASTLE (GB) | 2012-11-14 | — | — | EP | disclosed |
| US-20100130752-A1 | SYNTHESIS OF CYCLIC CARBONATES | UNIVERSITY OF NEWCASTLE UPON TYNE (GB) | 2010-05-27 | — | — | US | disclosed |
| CN-101679343-A | Synthesis of cyclic carbonates in the presence of dimeric aluminium (salen) catalysts | UNIV NEWCASTLE | 2010-03-24 | — | — | CN | disclosed |
| EP-2146977-A1 | SYNTHESIS OF CYCLIC CARBONATES IN THE PRESENCE OF DIMERIC ALUMINIUM (SALEN) CATALYSTS | University Of Newcastle-Upon Tyne (GB) | 2010-01-27 | — | — | EP | disclosed |
| WO-2008132474-A1 | SYNTHESIS OF CYCLIC CARBONATES IN THE PRESENCE OF DIMERIC ALUMINIUM (SALEN) CATALYSTS | UNIVERSITY OF NEWCASTLE UPON TYNE (GB) | 2008-11-06 | — | — | WO | disclosed |
| WO-1993002044-A1 | ACYCLIC 6-PHENYLSELENENYL PYRIMIDINE NUCLEOSIDES | BAKER CUMMINS PHARMACEUTICALS, INC. (US) | 1993-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130752-A1 | SYNTHESIS OF CYCLIC CARBONATES | CA2, SCO2, CA7 | ALDH1A1 3403/4885TSHR 4574/4885CHRM5 3133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.